1 Introduction to Research & Analysis Reports |
1.1 Recombinant Follicle Stimulating Hormone Market Definition |
1.2 Market Segments |
| 1.2.1 Segment by Type |
| 1.2.2 Segment by Application |
1.3 China Recombinant Follicle Stimulating Hormone Market Overview |
1.4 Methodology & Sources of Information |
| 1.4.1 Research Methodology |
| 1.4.2 Research Process |
| 1.4.3 Base Year |
2 China Recombinant Follicle Stimulating Hormone Overall Market Size |
2.1 China Recombinant Follicle Stimulating Hormone Market Size: 2021 VS 2027 |
2.2 China Recombinant Follicle Stimulating Hormone Revenue, Prospects & Forecasts: 2016-2027 |
2.3 China Recombinant Follicle Stimulating Hormone Sales: 2016-2027 |
3 Company Landscape |
3.1 Top Recombinant Follicle Stimulating Hormone Players in China Market |
3.2 Top China Recombinant Follicle Stimulating Hormone Companies Ranked by Revenue |
3.3 China Recombinant Follicle Stimulating Hormone Revenue by Companies |
3.4 China Recombinant Follicle Stimulating Hormone Sales by Companies |
3.5 China Recombinant Follicle Stimulating Hormone Price by Manufacturer (2016-2021) |
| 全:文：http://www.5269660.cn/2/99/2021-2027-China-Recombinant-Follicle-Stimulating-Hormone-Industry-In-Depth-Research-and-.html |
3.6 Top 3 and Top 5 Recombinant Follicle Stimulating Hormone Companies in China Market, by Revenue in 2020 |
3.7 Manufacturers Recombinant Follicle Stimulating Hormone Product Type |
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Follicle Stimulating Hormone Players in China Market |
| 3.8.1 List of Tier 1 Recombinant Follicle Stimulating Hormone Companies in China |
| 3.8.2 List of Tier 2 and Tier 3 Recombinant Follicle Stimulating Hormone Companies in China |
4 Sights by Type |
4.1 Overview |
| 4.1.1 By Type - China Recombinant Follicle Stimulating Hormone Market Size Markets, 2021 & 2027 |
| 4.1.2 75IU |
| 4.1.3 150IU |
| 4.1.4 Others |
4.2 By Type - China Recombinant Follicle Stimulating Hormone Revenue & Forecasts |
| 4.2.1 By Type - China Recombinant Follicle Stimulating Hormone Revenue, 2016-2021 |
| 4.2.2 By Type - China Recombinant Follicle Stimulating Hormone Revenue, 2022-2027 |
| 4.2.3 By Type - China Recombinant Follicle Stimulating Hormone Revenue Market Share, 2016-2027 |
4.3 By Type - China Recombinant Follicle Stimulating Hormone Sales & Forecasts |
| 4.3.1 By Type - China Recombinant Follicle Stimulating Hormone Sales, 2016-2021 |
| 4.3.2 By Type - China Recombinant Follicle Stimulating Hormone Sales, 2022-2027 |
| 4.3.3 By Type - China Recombinant Follicle Stimulating Hormone Sales Market Share, 2016-2027 |
4.4 By Type - China Recombinant Follicle Stimulating Hormone Price (Manufacturers Selling Prices), 2016-2027 |
5 Sights by Application |
5.1 Overview |
| 5.1.1 By Application - China Recombinant Follicle Stimulating Hormone Market Size, 2021 & 2027 |
| 5.1.2 Infertility Treatment |
| 5.1.3 Assisted Reproductive Technology |
5.2 By Application - China Recombinant Follicle Stimulating Hormone Revenue & Forecasts |
| 5.2.1 By Application - China Recombinant Follicle Stimulating Hormone Revenue, 2016-2021 |
| 5.2.2 By Application - China Recombinant Follicle Stimulating Hormone Revenue, 2022-2027 |
| 5.2.3 By Application - China Recombinant Follicle Stimulating Hormone Revenue Market Share, 2016-2027 |
5.3 By Application - China Recombinant Follicle Stimulating Hormone Sales & Forecasts |
| 5.3.1 By Application - China Recombinant Follicle Stimulating Hormone Sales, 2016-2021 |
| 5.3.2 By Application - China Recombinant Follicle Stimulating Hormone Sales, 2022-2027 |
| 5.3.3 By Application - China Recombinant Follicle Stimulating Hormone Sales Market Share, 2016-2027 |
5.4 By Application - China Recombinant Follicle Stimulating Hormone Price (Manufacturers Selling Prices), 2016-2027 |
6 Manufacturers & Brands Profiles |
6.1 Merck Serono |
| 6.1.1 Merck Serono Corporation Information |
| 6.1.2 Merck Serono Overview |
| 6.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales and Revenue in China Market (2016-2021) |
| 6.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Product Description |
| 6.1.5 Merck Serono Recent Developments |
| 2021-2027中國重組促卵泡激素行業深度研究及市場展望報告 |
6.2 MSD |
| 6.2.1 MSD Corporation Information |
| 6.2.2 MSD Overview |
| 6.2.3 MSD Recombinant Follicle Stimulating Hormone Sales and Revenue in China Market (2016-2021) |
| 6.2.4 MSD Recombinant Follicle Stimulating Hormone Product Description |
| 6.2.5 MSD Recent Developments |
6.3 Techwell |
| 6.3.1 Techwell Corporation Information |
| 6.3.2 Techwell Overview |
| 6.3.3 Techwell Recombinant Follicle Stimulating Hormone Sales and Revenue in China Market (2016-2021) |
| 6.3.4 Techwell Recombinant Follicle Stimulating Hormone Product Description |
| 6.3.5 Techwell Recent Developments |
6.4 GenSci |
| 6.4.1 GenSci Corporation Information |
| 6.4.2 GenSci Overview |
| 6.4.3 GenSci Recombinant Follicle Stimulating Hormone Sales and Revenue in China Market (2016-2021) |
| 6.4.4 GenSci Recombinant Follicle Stimulating Hormone Product Description |
| 6.4.5 GenSci Recent Developments |
6.5 Gedeon Richter |
| 6.5.1 Gedeon Richter Corporation Information |
| 6.5.2 Gedeon Richter Overview |
| 6.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales and Revenue in China Market (2016-2021) |
| 6.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Product Description |
| 6.5.5 Gedeon Richter Recent Developments |
6.6 Teva |
| 6.6.1 Teva Corporation Information |
| 6.6.2 Teva Overview |
| 6.6.3 Teva Recombinant Follicle Stimulating Hormone Sales and Revenue in China Market (2016-2021) |
| 6.6.4 Teva Recombinant Follicle Stimulating Hormone Product Description |
| 6.6.5 Teva Recent Developments |
7 China Recombinant Follicle Stimulating Hormone Production Capacity, Analysis |
7.1 China Recombinant Follicle Stimulating Hormone Production Capacity, 2016-2027 |
7.2 Recombinant Follicle Stimulating Hormone Production Capacity of Key Manufacturers in China Market |
8 Key Market Trends, Opportunity, Drivers and Restraints |
8.1 Market Opportunities & Trends |
8.2 Market Drivers |
8.3 Market Restraints |
9 Recombinant Follicle Stimulating Hormone Supply Chain Analysis |
9.1 Recombinant Follicle Stimulating Hormone Industry Value Chain |
9.2 Recombinant Follicle Stimulating Hormone Upstream Market |
9.3 Recombinant Follicle Stimulating Hormone Downstream and Clients |
| 2021-2027中國重組促卵泡激素行業深度研究及市場展望報告 |
9.4 Marketing Channels Analysis |
| 9.4.1 Marketing Channels |
| 9.4.2 Recombinant Follicle Stimulating Hormone Distributors and Sales Agents in China Market |
10 Conclusion |
11 Appendix |
11.1 Note |
11.2 Examples of Clients |
11.3 Author Details |
11.4 Disclaimer |
| List of Tables |
| Table 1. Key Players of Recombinant Follicle Stimulating Hormone in China Market |
| Table 2. Top Recombinant Follicle Stimulating Hormone Players in China Market, Ranking by Revenue (2019) |
| Table 3. China Recombinant Follicle Stimulating Hormone Revenue by Companies, (US$, Mn), 2016-2021 |
| Table 4. China Recombinant Follicle Stimulating Hormone Revenue Share by Companies, 2016-2021 |
| Table 5. China Recombinant Follicle Stimulating Hormone Sales by Companies, (K Doses), 2016-2021 |
| Table 6. China Recombinant Follicle Stimulating Hormone Sales Share by Companies, 2016-2021 |
| Table 7. Key Manufacturers Recombinant Follicle Stimulating Hormone Price (2016-2021) & (USD/Dose) |
| Table 8. Manufacturers Recombinant Follicle Stimulating Hormone Product Type |
| Table 9. List of Tier 1 Recombinant Follicle Stimulating Hormone Companies, Revenue (US$, Mn) in 2020 and Market Share |
| Table 10. List of Tier 2 and Tier 3 Recombinant Follicle Stimulating Hormone Companies, Revenue (US$, Mn) in 2020 and Market Share |
| Table 11. Major Manufacturers of 75IU |
| Table 12. Major Manufacturers of 150IU |
| Table 13. By Type – China Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2021 & 2027 |
| Table 14. By Type - China Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2016-2021 |
| Table 15. By Type - China Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2022-2027 |
| Table 16. By Type - China Recombinant Follicle Stimulating Hormone Sales (K Doses), 2016-2021 |
| Table 17. By Type - China Recombinant Follicle Stimulating Hormone Sales (K Doses), 2022-2027 |
| Table 18. By Application – China Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2021 VS 2027 |
| Table 19. By Application - China Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2016-2021 |
| Table 20. By Application - China Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2022-2027 |
| Table 21. By Application - China Recombinant Follicle Stimulating Hormone Sales (K Doses), 2016-2021 |
| Table 22. By Application - China Recombinant Follicle Stimulating Hormone Sales (K Doses), 2022-2027 |
| Table 23. Merck Serono Corporation Information |
| Table 24. Merck Serono Description and Major Businesses |
| Table 25. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) |
| Table 26. Merck Serono Recombinant Follicle Stimulating Hormone Product |
| Table 27. Merck Serono Recent Developments |
| Table 28. MSD Corporation Information |
| 2021-2027 Zhong Guo Zhong Zu Cu Luan Pao Ji Su Xing Ye ShenDu YanJiu Ji Shi Chang ZhanWang Bao Gao |
| Table 29. MSD Description and Major Businesses |
| Table 30. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) |
| Table 31. MSD Recombinant Follicle Stimulating Hormone Product |
| Table 32. MSD Recent Developments |
| Table 33. Techwell Corporation Information |
| Table 34. Techwell Description and Major Businesses |
| Table 35. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) |
| Table 36. Techwell Recombinant Follicle Stimulating Hormone Product |
| Table 37. Techwell Recent Developments |
| Table 38. GenSci Corporation Information |
| Table 39. GenSci Description and Major Businesses |
| Table 40. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) |
| Table 41. GenSci Recombinant Follicle Stimulating Hormone Product |
| Table 42. GenSci Recent Developments |
| Table 43. Gedeon Richter Corporation Information |
| Table 44. Gedeon Richter Description and Major Businesses |
| Table 45. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) |
| Table 46. Gedeon Richter Recombinant Follicle Stimulating Hormone Product |
| Table 47. Gedeon Richter Recent Developments |
| Table 48. Teva Corporation Information |
| Table 49. Teva Description and Major Businesses |
| Table 50. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) |
| Table 51. Teva Recombinant Follicle Stimulating Hormone Product |
| Table 52. Teva Recent Developments |
| Table 53. Recombinant Follicle Stimulating Hormone Production Capacity (K Doses) of Key Manufacturers in China Market, 2019-2021 (K Doses) |
| Table 54. China Recombinant Follicle Stimulating Hormone Capacity Market Share of Key Manufacturers, 2019-2021 |
| Table 55. Recombinant Follicle Stimulating Hormone Market Opportunities & Trends in China Market |
| Table 56. Recombinant Follicle Stimulating Hormone Market Drivers in China Market |
| Table 57. Recombinant Follicle Stimulating Hormone Market Restraints in China Market |
| Table 58. Recombinant Follicle Stimulating Hormone Raw Materials |
| Table 59. Recombinant Follicle Stimulating Hormone Raw Materials Suppliers in China Market |
| Table 60. Typical Recombinant Follicle Stimulating Hormone Downstream |
| Table 61. Recombinant Follicle Stimulating Hormone Downstream Clients in China Market |
| Table 62. Recombinant Follicle Stimulating Hormone Distributors and Sales Agents in China Market |
| List of Figures |
| Figure 1. Recombinant Follicle Stimulating Hormone Product Picture |
| Figure 2. Recombinant Follicle Stimulating Hormone Segment by Type |
| Figure 3. Recombinant Follicle Stimulating Hormone Segment by Application |
| Figure 4. China Recombinant Follicle Stimulating Hormone Market Overview: 2020 |
| Figure 5. China Recombinant Follicle Stimulating Hormone Market Size: 2021 VS 2027 (US$, Mn) |
| 2021-2027中國の組換え卵胞刺激ホルモン産業の詳細な調査と市場調査レポート |
| Figure 6. China Recombinant Follicle Stimulating Hormone Revenue, 2016-2027 (US$, Mn) |
| Figure 7. Recombinant Follicle Stimulating Hormone Sales in China Market: 2016-2027 (K Doses) |
| Figure 8. The Top 3 and 5 Players Market Share by Recombinant Follicle Stimulating Hormone Revenue in 2020 |
| Figure 9. 75IU Product Picture |
| Figure 10. 150IU Product Picture |
| Figure 11. Others Product Picture |
| Figure 12. By Type - China Recombinant Follicle Stimulating Hormone Sales Market Share, 2016-2027 |
| Figure 13. By Type - China Recombinant Follicle Stimulating Hormone Revenue Market Share, 2016-2027 |
| Figure 14. By Type - China Recombinant Follicle Stimulating Hormone Price (USD/Dose), 2016-2027 |
| Figure 15. Infertility Treatment |
| Figure 16. Assisted Reproductive Technology |
| Figure 17. By Application - China Recombinant Follicle Stimulating Hormone Sales Market Share, 2016-2027 |
| Figure 18. By Application - China Recombinant Follicle Stimulating Hormone Revenue Market Share, 2016-2027 |
| Figure 19. By Application - China Recombinant Follicle Stimulating Hormone Price (USD/Dose), 2016-2027 |
| Figure 20. Merck Serono Recombinant Follicle Stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 21. MSD Recombinant Follicle Stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 22. Techwell Recombinant Follicle Stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 23. GenSci Recombinant Follicle Stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 24. Gedeon Richter Recombinant Follicle Stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 25. Teva Recombinant Follicle Stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 26. China Recombinant Follicle Stimulating Hormone Production Capacity (K Doses), 2016-2027 |
| Figure 27. Recombinant Follicle Stimulating Hormone Industry Value Chain |
| Figure 28. Marketing Channels |
…
如需購買《2021-2027 China Recombinant Follicle Stimulating Hormone Industry In-Depth Research and Market Outlook Report》，編號：3186992
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號